Health · Medical Research · 1 hr ago
Computer-designed bird flu vaccine protects mice against three H5N1 strains
A computer-designed vaccine protected mice against three H5N1 strains in tests by a team at the University of Cambridge.
The strains came from three branches of bird flu that have infected people.
The vaccine uses mRNA instructions for three designed antigens, selected using genetic data from H5 viruses collected worldwide.
Existing bird flu vaccines held in government stockpiles are based on single virus samples, while H5 viruses continue to evolve into different branches.
All vaccinated mice survived exposure, while half of the mice given a stockpile-style vaccine died after exposure to one strain.
The result offers early evidence of broader protection, but the tests were in animals, not people, and the vaccine has not been given to humans.
A computer-designed bird flu vaccine protected mice against three H5N1 strains, according to a study led by a University of Cambridge team.
All mice given the vaccine survived exposure to their assigned virus, while half of the mice given a stockpile-style vaccine died after exposure to clade 1.
The vaccine uses mRNA instructions for three antigens designed from genetic sequences of H5 viruses collected worldwide.
The tests were conducted in mice and ferrets, and the vaccine has not been given to people.
Researchers said the approach aims to address the evolution and spread of multiple H5 virus lineages.
- Who
- A University of Cambridge team led by Jonathan Heeney developed and tested the vaccine.
- What
- A computer-designed vaccine protected mice against three H5N1 strains.
- When
- The article was published on November 10, 2026; the study date is not stated.
- Where
- The research was led by a team at the University of Cambridge. The location of the animal tests is not stated.
- Why
- The vaccine was designed to provide protection across H5N1 strains that have evolved into multiple lineages.
This story does not have two clearly opposing sides.
The team used genetic sequences of H5 viruses collected worldwide to design vaccine antigens.
Researchers exposed separate groups of mice to three H5N1 viruses from different clades.
All mice given the designed vaccine survived, while half of the mice given the stockpile-style vaccine died after exposure to clade 1.
- Virus strains tested
- Clade 1, clade 2.3.2.1e and clade 2.3.4.4b
- Designed antigens
- 3
- Stockpile-style vaccine outcome
- Half of the mice died after exposure to clade 1
- Human testing
- The vaccine has not been given to a person
- Study lead
- Jonathan Heeney, University of Cambridge
What people are saying
For more than 70 years, vaccines against rapidly evolving viruses have largely been designed by looking backwards at the pathogen that already exists
These vaccines are based on single viral isolates, whereas H5Nx viruses have continued to evolve and diversify into multiple lineages around the world
In many cases, viral evolution has outpaced the strains on which those stockpiled vaccines were originally based